# Celaid Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/celaid-therapeutics

- Industry: Biotechnology
- Headquarters: Tokyo, Japan
- Website: www.celaidtx.com/
- Total disclosed funding: $10M
- Latest round: Series B (Oct 7, 2025)
- Investors on record: 5

## About

Based in Tokyo, Japan, and founded in 2020, Celaid Therapeutics Inc. operates as a biotechnology research company that engages in the research and development of regenerative medicine and products using human hematopoietic stem cells. In October 2025, Celaid Therapeutics Inc. raised JPY 555 million in series B funding from returning investors Osaka University Venture Capital, The University of Tokyo Edge Capital Partners, Techno Science, and Joyo Capital Partners. This round was part of a larger JPY 1.06 billion series B equity and grant funding.

The company is working on the development of cell therapies for intractable blood diseases including blood/hematologic cancers such as leukemia and genetic diseases, by using the proliferation of hematopoietic stem cells in umbilical cord blood and peripheral blood. The company uses its platform technology of in vitro expansion of functional hematopoietic stem cells, without choosing its origins, including bone marrow, cord blood, or peripheral blood.

The company plans to use the October 2025 funding to support the preparation for the US clinical trials of its medicine and to expand the application of its therapeutic technology.

## Funding rounds

- Series B, Oct 7, 2025, $3.8M — University of Tokyo Edge Capital Partners, Joyo Capital Partners, Osaka University Venture Capital, Techno Science
- Series A, May 8, 2024, $3M — University of Tokyo Edge Capital Partners, Joyo Capital Partners, Osaka University Venture Capital, Techno Science
- Series A, Oct 21, 2022, $3.4M — University of Tokyo Edge Capital Partners, Tsukuba Institute of Research, Techno Science

## Investors

- University of Tokyo Edge Capital Partners (https://capitalatlas.ai/funds/university-of-tokyo-edge-capital-partners) — Series A, Series B
- Tsukuba Institute of Research (https://capitalatlas.ai/funds/tsukuba-institute-of-research) — Series A
- Techno Science — Series A, Series B
- Joyo Capital Partners (https://capitalatlas.ai/funds/joyo-capital-partners) — Series A, Series B
- Osaka University Venture Capital (https://capitalatlas.ai/funds/osaka-university-venture-capital) — Series A, Series B